In vivo marking of Rhesus monkey lymphocytes by adeno-associated viral vectors: Direct comparison with retroviral vectors

Blood

Volumn 94, Issue 7, 1999, Pages 2263-2270

  Hanazono, Yutaka ^a   Brown, Kevin E ^a   Handa, Atsushi ^a   Metzger, Mark E ^a   Heim, Dominik ^a   Kurtzman, Gary J ^a   Donahue, Robert E ^a   Dunbar, Cynthia E ^a  

^a Bldg 10 ^*

Author keywords

[No Author keywords available]

Indexed keywords

BETA GALACTOSIDASE; NEOMYCIN; VIRUS VECTOR;

ADENO ASSOCIATED VIRUS; ANIMAL EXPERIMENT; ARTICLE; CONTROLLED STUDY; DNA SEQUENCE; GENE MUTATION; GENE THERAPY; NONHUMAN; PERIPHERAL LYMPHOCYTE; PRIORITY JOURNAL; RETROVIRUS; RHESUS MONKEY; T LYMPHOCYTE;

EID: 0033214888     PISSN: 00064971     EISSN: None     Source Type: Journal    
DOI: 10.1182/blood.v94.7.2263.419k36_2263_2270     Document Type: Article

References (42)

1. Hwu P, Rosenberg SA: Gene therapy using lymphocyte modification, in DeVita VT, Hellman S, Rosenberg SA (eds): Biologic Therapy of Cancer. Philadelphia, PA, Lippincott, 1995, p 727
2. Hege KM, Roberts MR: T-cell gene therapy. Curr Opin Biotechnol 7:629, 1996
3. Mullen CA, Snitzer K, Culver KW, Morgan RA, Anderson WF, Blaese RM: Molecular analysis of T lymphocyte-directed gene therapy for adenosine deaminase deficiency: Long-term expression in vivo of genes introduced with a retroviral vector. Hum Gene Ther 7:1123, 1996
4. Riddell SR, Elliott M, Lewinsohn DA, Gilbert MJ, Wilson L, Manley SA, Lupton SD, Overell RW, Reynolds TC, Corey L, Greenberg PD: T-cell mediated rejection of gene-modified HIV-specific cytotoxic T lymphocytes in HIV-infected patients. Nat Med 2:216, 1996
5. Selvaggi TA, Walker RE, Fleisher TA: Development of antibodies to fetal calf serum with arthus-like reactions in human immunodeficiency virus-infected patients given syngeneic lymphocyte infusions. Blood 89:776, 1997
6. Challita P, Kohn DB: Lack of expression from a retroviral vector after transduction of murine hematopoietic stem cells is associated with methylation in vivo. Proc Natl Acad Sci USA 91:2567, 1994
7. Berns KI, Bergoin M, Bloom M, Lederman M, Muzyczka N, Siegl G, Tal J, Tattersall P: Family Parvoviridae, in Murphy FA, Fauquet CM, Bishop DHL, Ghabrial SA, Jarvis AW, Martelli GP, Mayo MA, Summers MD (eds): Virus Taxonomy. Classification and Nomenclature of Viruses. New York, NY, Springer-Verlag, 1995, p 169
8. Berns KI: Parvoviridae: The viruses and their replication, in Fields BN, Knipe DM, Howley PM (eds): Fields Virology. Philadelphia, PA, Lippincott-Raven, 1996, p 2173
9. Samulski RJ, Chang LS, Shenk T: Helper-free stocks of recombinant adeno-associated viruses: normal integration does not require viral gene expression. J Virol 63:3822, 1989
10. Grossman Z, Mendelson E, Brok-Simoni F, Mileguir F, Leitner Y, Rechavi G, Ramot B: Detection of adeno-associated virus type 2 in human peripheral blood cells. J Gen Virol 73:961, 1992
11. Podsakoff G, Wong JKK, Chatterjee S: Efficient gene transfer into nondividing cells by adeno-associated virus-based vectors. J Virol 68:5656, 1994
12. Clark KR, Sferra TJ, Johnson PR: Recombinant adenoassociated viral vectors mediate long-term transgene expression in muscle. Hum Gene Ther 8:659, 1997
13. Miao CH, Snyder RO, Schowalter DB, Patjin GA, Donahue B, Winther B, Kay MA: The kinetics of rAAV integration in the liver. Nat Genet 19:13, 1998
14. Monahan PE, Samulski RJ, Tazelaar J, Xiao X, Nichols TC, Bellinger DA, Read MS, Walsh CE: Direct intramuscular injection with recombinant AAV vectors results in sustained expression in a dog model of hemophilia. Gene Ther 5:40, 1998
15. Kearns WG, Afione SA, Fulmer SB, Pang MC, Erikson D, Egan M, Landrum MJ, Flotte TR, Cutting GR: Recombinant adenoassociated virus (AAV-CFTR) vectors do not integrate in a site-specific fashion in an immortalized epithelial cell line. Gene Ther 3:748, 1996
16. Ponnazhagan S, Erikson D, Kearns WG, Zhou SZ, Nahreini P, Wang XS, Srivastava A: Lack of site-specific integration of the recombinant adeno-associated virus 2 genomes in human cells. Hum Gene Ther 8:275, 1997
17. Samulski RJ, Zhu X, Xiao X, Brook JD, Hausman DE, Epstein N, Hunter LA: Targeted integration of adeno-associated virus (AAV) into human chromosome 19. EMBO J 10:3941, 1991
18. Kotin RM, Menninger JC, Ward DC, Berns KI: Mapping and direct visualization of a region-specific viral DNA integration site on chromosome 19q13-qter. Genomics 10:831, 1991
19. Gardner JP, Zhu H, Colosi PC, Kurtzman GJ, Scadden DT: Robust, but transient expression of adeno-associated virus-transduced genes during human T lymphopoiesis. Blood 90:4854, 1997
20. Chiorini JA, Wendtner CM, Urcelay E, Safer B, Hallek M, Kotin RM: High-efficiency transfer of the T cell co-stimulatory molecule B7-2 to lymphoid cells using high-liter recombinant adeno-associated virus vectors. Hum Gene Ther 6:1531, 1995
21. Chen JD, Yang Q, Yang AG, Marasco WA, Chen SY: Intra- and extracellular immunization against HIV-I infection with lymphocytes transduced with an AAV vector expressing a human anti-gp120 antibody. Hum Gene Ther 7:1515, 1996
22. Bunnell BA, Muul LM, Donahue RE, Blaese RM, Morgan RA: High-efficiency retroviral-mediated gene transfer into human and nonhuman primate peripheral blood lymphocytes. Proc Natl Acad Sci USA 92:7739, 1995
23. Kohn DB, Hershfield MS, Carbonaro D, Shigeoka A, Brooks J, Smogorzewska EM, Barsky LW, Chan R, Burotito F, Annett G, Nolta JA, Crooks G, Kapoor N, Elder M, Wara D, Bowen T, Madsen E, Snyder FF, Bastian J, Muul L, Blaese RM, Weinberg K, Parkman R: T lymphocytes with a normal ADA gene accumulate after transplantation of transduced autologous umbilical cord blood CD34+ cells in ADA-deficient SCID neonates. Nat Med 4:775, 1998
24. Pear WS, Nolan GP, Scott ML, Baltimore D: Production of high-titer helper-free retroviruses by transient transfection. Proc Natl Acad Sci USA 90:8392, 1993
25. Migita M, Medin JA, Pawliuk R, Jacobson S, Nagle JW, Anderson S, Amiri M, Humphries RK, Karlsson S: Selection of transduced CD34+ progenitors and enzymatic correction of cells from Gaucher patients, with bicistronic vectors. Proc Natl Acad Sci USA 92:12075, 1995
26. Hanazono Y, Dunbar CE, Emmons RVB: Green fluorescent protein retroviral vectors: Low titer and high recombination frequency suggest a selective disadvantage. Hum Gene Ther 8:1313, 1997
27. Heim DA, Hanazono Y, Childs R, Metzger M, Donahue RE, Dunbar CE: In vivo persistence of rhesus lymphocytes transduced with a non-expressing retroviral vector compared to rapid clearance of lymphocytes transduced with a neo-expressing vector. Blood 92:2833, 1998 (abstr, suppl 1)
28. Hargrove PW, Vanin EF, Kurtzman GJ, Nienhuis AW: High-level globin gene expression mediated by a recombinant adeno-associated virus genome that contains the 3′ gamma globin gene regulatory element and integrates as tandem copies in erythroid cells. Blood 89:2167, 1997
29. Tamayose K, Hirai Y, Shimada T: A new strategy for large-scale preparation of high-titer recombinant adeno-associated virus vectors by using packaging cell lines and sulfonated cellulose column chromatography. Hum Gene Ther 7:507, 1996
30. Salvetti A, Oreve S, Chadeuf G, Favre D, Cherel Y, Champion-Arnaud P, David-Ameline J, Mouiller P: Factors influencing recombinant adeno-associated virus production. Hum Gene Ther 9:695, 1998
31. Ferreria FK, Xiao X, McCarty D, Samulski RJ: New developments in the generation of Ad-free, high-titer rAAV gene therapy vectors. Nat Med 3:1295, 1997
32. Summerford C, Samulski RJ: Membrane-associated heparan sulfate protoglycan is a receptor for adeno-associated virus type 2 virus. J Virol 72:1438, 1998
33. Qing K, Mah C, Hansen J, Zhou S, Dwarki V, Srivastava A: Human fibroblast growth factor receptor 1 is a co-receptor for infection by adeno-associated virus 2. Nat Med 5:71, 1999
34. Summerford C, Bartlett JS, Samulski RJ: αVβ5 integrin: A co-receptor for adeno-associated virus type 2 infection. Nat Med 5:78, 1999
35. Ohshiro Y, Murakami T, Matsuda K, Nishioka K, Yoshida K, Yamamoto N: Role of cell surface glycosaminoglycans of human T cells in human immunodeficiency virus type-1 (HIV-1) infection. Microbiol Immunol 40:827, 1996
36. Zhao XM, Byrd VM, McKeehan WL, Reich MB, Miller GG, Thomas JW: Costimulation of human CD4+ T cells by fibroblast growth factor-1 (acidic fibroblast growth factor). J Immunol 155:3904, 1995
37. Alexander IE, Russell DW, Miller AD: DNA-damaging agents greatly increase the transduction of nondividing cells by adeno-associated virus vectors. J Virol 68:8282, 1994
38. Russell DW, Alexander IE, Miller AD: DNA synthesis and topoisomerase inhibitors increase transduction by adeno-associated virus vectors. Proc Natl Acad Sci USA 92:5719, 1995
39. Verzeletti S, Bonini C, Marktel S, Nobili N, Ciceri F, Travesari C, Bordignon C: Herpes simplex virus thymidine kinase gene transfer for controlled graft-versus-host disease and graft-versus leukemia: Clinical follow-up and improved new vectors. Hum Gene Ther 10:2243, 1998
40. Zier KS, Gansbacher B: The impact of gene therapy on T cell function in cancer. Hum Gene Ther 6:1259, 1995
41. Shaughnessy E, Lu D, Chatterjee S, Wong KK: Parvoviral vectors for the gene therapy of cancer. Semin Oncol 23:159, 1996
42. Qui J, Mizukami H, Brown KE: Adeno-associated virus 2 co-receptors? Nat Med 5:467, 1999